| BACCARANI, M., N. SHAH, H. KANTARIJAN, J. CORTES, S. SHAH, M. AYALA, B. MOIRAGHI, Jiří MAYER, M. BRADLEY-GARELIK, C. ZHU a A. HOCHHAUS. Dasatinib compared to imatinib in patients with newly diagnosed chronic-phase chronic myelogenous leukemia (CML-CP): results from the randomized phase 3 dasision tria. In Haematologica, 15th Congress of the European Hematology Association, Spain, Barcelona, 2010. 2010. ISSN 0390-6078. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{893890,
author = {Baccarani, M. and Shah, N. and Kantarijan, H. and Cortes, J. and Shah, S. and Ayala, M. and Moiraghi, B. and Mayer, Jiří and BradleyandGarelik, M. and Zhu, C. and Hochhaus, A.},
booktitle = {Haematologica, 15th Congress of the European Hematology Association, Spain, Barcelona, 2010},
language = {eng},
title = {Dasatinib compared to imatinib in patients with newly diagnosed chronic-phase chronic myelogenous leukemia (CML-CP): results from the randomized phase 3 dasision tria},
year = {2010}
}
TY - CONF
ID - 893890
AU - Baccarani, M. - Shah, N. - Kantarijan, H. - Cortes, J. - Shah, S. - Ayala, M. - Moiraghi, B. - Mayer, Jiří - Bradley-Garelik, M. - Zhu, C. - Hochhaus, A.
PY - 2010
TI - Dasatinib compared to imatinib in patients with newly diagnosed chronic-phase chronic myelogenous leukemia (CML-CP): results from the randomized phase 3 dasision tria
ER -
BACCARANI, M., N. SHAH, H. KANTARIJAN, J. CORTES, S. SHAH, M. AYALA, B. MOIRAGHI, Jiří MAYER, M. BRADLEY-GARELIK, C. ZHU a A. HOCHHAUS. Dasatinib compared to imatinib in patients with newly diagnosed chronic-phase chronic myelogenous leukemia (CML-CP): results from the randomized phase 3 dasision tria. In \textit{Haematologica, 15th Congress of the European Hematology Association, Spain, Barcelona, 2010}. 2010. ISSN~0390-6078.
|
